a genome-wide level. GENEVA’s initial efforts will focus on SNP analysis, yet it is actively pursuing the role of other forms of genetic variation, including CNVs. Moreover, sharing GENEVA’s growing repository of data with the broader scientific community should accelerate identification of variants related to complex diseases and identify opportunities for developing effective interventions. In parallel to meeting the aims of the consortium, GENEVA is intended to provide and broadly disseminate analytical and bioinformatic approaches for use in the design and conduct of future GWAS.
